Author:
Weibel Daniel,Sturkenboom Miriam,Black Steven,de Ridder Maria,Dodd Caitlin,Bonhoeffer Jan,Vanrolleghem Ann,van der Maas Nicoline,Lammers Gert Jan,Overeem Sebastiaan,Gentile Angela,Giglio Norberto,Castellano Vanesa,Kwong Jeffrey C.,Murray Brian J.,Cauch-Dudek Karen,Juhasz Diana,Campitelli Michael,Datta Alexandre N.,Kallweit Ulf,Huang Wan-Ting,Huang Yu-Shu,Hsu Chung-Yao,Chen Hsi-Chung,Giner-Soriano Maria,Morros Rosa,Gaig Carles,Tió Ester,Perez-Vilar Silvia,Diez-Domingo Javier,Puertas Francisco Javier,Svenson Lawrence W.,Mahmud Salaheddin M.,Carleton Bruce,Naus Monika,Arnheim-Dahlström Lisen,Pedersen Lars,DeStefano Frank,Shimabukuro Tom T.
Funder
U.S. Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference36 articles.
1. Medical Products Agency. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix – a first and preliminary report, by the Medical Products Agency; 2011. https://lakemedelsverket.se/upload/nyheter/2011/PandemrixRegReport110328.pdf.
2. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland;Partinen;PLoS ONE,2012
3. European Medicines Agency. Pandemrix: EPAR - Product Information; 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500038121&mid=WC0b01ac058009a3dc.
4. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden;Bardage;BMJ,2011
5. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland;Nohynek;PLoS ONE,2012